Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY.

Cecilia Becattini,Ugo Pace,Fabio Rondelli,Paolo Delrio,Graziano Ceccarelli,Michela Boncompagni,Luigina Graziosi,Adriana Visonà,Damiano Chiari,Giampiero Avruscio,Stefania Frasson,Gualberto Gussoni,Alessia Biancafarina,Giuseppe Camporese,Annibale Donini,Andrea Fares Bucci,Giancarlo Agnelli

European Journal of Internal Medicine（2020）

引用 10|浏览86

暂无评分

摘要

•Benefit of extended VTE prophylaxis after laparoscopic cancer surgery undefined.•A randomized, double-blind study in laparoscopic surgery for colorectal cancer.•To assess the clinical benefit of extended prophylaxis with rivaroxaban.•PROLAPS II is the first study with an oral anti-Xa agent in cancer surgery.

查看译文

关键词

Venous thromboembolism,Pulmonary embolism,Rivaroxaban,Cancer,Prevention

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要